Loren Peterson

Loren is a Managing Director of the General Partner of Venture Investors Early Stage Fund V L.P. and a Managing Director and Chief Financial Officer of the Fund Manager, Venture Investors LLC.  He joined Venture Investors in 2012 after serving as a consultant to the company since 2011.

Loren is responsible for all operations for Venture Investors’ venture capital partnerships including: investor relations, financial reporting, legal, accounting, valuation analyses, and audit and tax compliance. He works closely with our portfolio companies on accounting and tax issues, as well as providing assistance to Venture Investors’ investment team on accounting and financial matters related to portfolio investments.  He also serves on the Board of Directors of ProCertus BioPharm, Inc.

Loren is especially qualified to serve as Venture Investors’ Chief Financial Officer, having worked for 15 years as a CPA and another 17 years as an executive in the pharmaceutical and drug development industry.  He has extensive operational experience with small-to-medium-sized businesses and has successfully financed, grown and exited several drug development companies.  He helped raise over $100 million for these companies, negotiated multiple licensing, manufacturing and other business development agreements, and has been responsible for all administrative and operational aspects of these companies.  As a result, Loren has the experience to both manage Venture Investors’ internal business operations and to provide an insider’s perspective on the needs and challenges facing our portfolio companies.

Loren previously served as President, CEO and a director of ZyStor Therapeutics, Inc., a VIESF III portfolio company, until August 2010 when ZyStor was acquired by BioMarin Pharmaceutical Inc.  Previously, Loren was President and CEO of Sheffield Pharmaceuticals, a public, development-stage respiratory drug delivery company, and Vice President and Chief Financial Officer of Bock Pharmacal Company until its acquisition by Sanofi Pharmaceuticals.  Earlier in his career, Loren was a partner at Coopers & Lybrand (now PriceWaterhouse Coopers), where he provided accounting and audit services to companies in a variety of industries.
Loren graduated with High Distinction from theUniversity ofNebraska –Lincoln with a Bachelor of Science degree in Business Administration.  He holds a CPA certificate and is a member of the American Institute of Certified Public Accountants.